副腎皮質ステロイドの世界市場レポート 2025年

副腎皮質ステロイド市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.2％で72億4,000万米ドルに成長します。予測期間の成長は、慢性疾患の罹患率の上昇、リウマチ領域での用途拡大、ドラッグデリバリーの進歩、高齢者人口の増加、副腎皮質ステロイド治療薬の研究開発に起因すると考えられます。予測期間における主な動向としては、免疫調節作用の重視、バイオシミラー市場の成長、併用療法の開発、小児専用製剤、規制遵守の重視などが挙げられます。

がん治療に対する需要の高まりが、今後数年間の副腎皮質ステロイド市場の拡大を牽引すると予想されます。がん治療には、手術、化学療法、放射線療法、免疫療法、標的治療など、がん細胞の除去や症状の緩和を目的とした様々な治療法が含まれます。がん治療の需要増加には、がん罹患率の上昇、がんに対する認識と検診の強化、ヘルスケアへのアクセスの向上、支持療法サービスの利用可能性など、いくつかの要因が寄与しています。副腎皮質ステロイドは、症状を緩和し、がん治療の忍容性を向上させることで、患者の転帰を改善し、包括的ながん治療の需要をさらに後押しします。例えば、2024年5月、英国の国民保健サービス（NHS）は、1営業日あたり1,400人以上の患者ががん治療を開始し、治療活動が過去最高を記録したと報告しました。2023年4月から2024年3月までに、約34万人が初めてがん治療を受けた。その結果、がん治療に対する需要の増加が副腎皮質ステロイド市場の成長を後押ししています。

呼吸器疾患の有病率の上昇は、今後の副腎皮質ステロイド市場の成長を促進すると予測されます。副腎皮質ステロイドは、鼻炎、肺炎、サルコイドーシス、喘息増悪、COPD増悪、アナフィラキシー、蕁麻疹、血管浮腫などの症状に対して一般的に処方されます。喘息やCOPDの増悪、アナフィラキシー、蕁麻疹や血管浮腫、鼻炎、肺炎、サルコイドーシス、間質性肺疾患など、多くの呼吸器疾患は副腎皮質ステロイドで治療されます。例えば、2024年5月、全国的な非営利団体であるAsthma Australiaは、オーストラリアにおける喘息死亡率が2021年の349人から2022年には455人に増加したことを報告し、この慢性呼吸器疾患に関する動向を浮き彫りにしました。その結果、呼吸器疾患の罹患率の増加が副腎皮質ステロイド市場を前進させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界副腎皮質ステロイド PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の副腎皮質ステロイド市場：成長率分析
• 世界の副腎皮質ステロイド市場の実績：規模と成長, 2019-2024
• 世界の副腎皮質ステロイド市場の予測：規模と成長, 2024-2029, 2034F
• 世界副腎皮質ステロイド総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の副腎皮質ステロイド市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• グルココルチコイド
• ミネラルコルチコイド
• 世界の副腎皮質ステロイド市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚アレルギー
• リウマチ科の適応症
• 内分泌学
• 急性呼吸器疾患
• その他の用途
• 世界の副腎皮質ステロイド市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 調査機関
• その他のエンドユーザー
• 世界の副腎皮質ステロイド市場グルココルチコイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒドロコルチゾン
• プレドニゾン
• デキサメタゾン
• メチルプレドニゾロン
• トリアムシノロン
• ベタメタゾン
• その他のグルココルチコイド
• 世界の副腎皮質ステロイド市場ミネラルコルチコイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルドロコルチゾン
• アルドステロン
• その他のミネラルコルチコイド

第7章 地域別・国別分析

• 世界の副腎皮質ステロイド市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の副腎皮質ステロイド市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副腎皮質ステロイド市場：競合情勢
• 副腎皮質ステロイド市場：企業プロファイル
  • McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sumitomo Corporation
• Novartis International AG
• Sanofi SA
• Bristol Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 副腎皮質ステロイド市場2029：新たな機会を提供する国
• 副腎皮質ステロイド市場2029：新たな機会を提供するセグメント
• 副腎皮質ステロイド市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Corticosteroid therapy involves administering treatment in various forms to suppress the immune system and alleviate inflammation. It is employed in addressing conditions such as asthma, hay fever, and urticaria (hives) associated with allergy symptoms. Corticosteroids, also referred to as steroids, represent a category of anti-inflammatory medications.

The primary classifications of corticosteroid therapy include glucocorticoids and mineralocorticoids. Glucocorticoids, a specific type of corticosteroid hormone, are highly effective in immune system suppression and inflammation reduction. This therapeutic approach finds application in treating skin allergies, rheumatology indications, endocrinology, and acute respiratory diseases in medical facilities, clinics, research institutes, and other healthcare settings.

The corticosteroids therapy market research report is one of a series of new reports from The Business Research Company that provides corticosteroids therapy market statistics, including corticosteroids therapy industry global market size, regional shares, competitors with a corticosteroids therapy market share, detailed corticosteroids therapy market segments, market trends and opportunities, and any further data you may need to thrive in the corticosteroids therapy industry. This corticosteroid therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The corticosteroids market size has grown steadily in recent years. It will grow from $5.47 billion in 2024 to $5.7 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to treatment of inflammatory conditions, autoimmune disorders and immune system suppression, respiratory conditions and asthma management, allergic reactions and dermatological applications, cancer treatment support.

The corticosteroids market size is expected to see strong growth in the next few years. It will grow to $7.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising incidence of chronic diseases, expanding applications in rheumatology, advancements in drug delivery, geriatric population growth, research and development in corticosteroid therapeutics. Major trends in the forecast period include immunomodulatory effects emphasis, biosimilar market growth, combination therapies development, pediatric-specific formulations, regulatory compliance focus.

The growing demand for cancer treatment is expected to drive the expansion of the corticosteroid market in the coming years. Cancer treatment includes various therapies-such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments-aimed at eliminating cancer cells and alleviating symptoms. Several factors contribute to the increasing demand for cancer treatment, including the rising incidence of cancer, enhanced awareness and screening efforts, better access to healthcare, and the availability of supportive care services. Corticosteroids help alleviate symptoms and improve the tolerability of cancer treatments, which leads to better patient outcomes and further supports the demand for comprehensive cancer care. For example, in May 2024, the National Health Service (NHS) in the UK reported that treatment activity reached an all-time high, with over 1,400 patients beginning cancer treatment each working day. From April 2023 to March 2024, nearly 340,000 individuals received their first cancer treatment. Consequently, the increasing demand for cancer treatment is propelling the growth of the corticosteroid market.

The rising prevalence of respiratory diseases is anticipated to drive the growth of the corticosteroids market in the future. Corticosteroids are commonly prescribed for conditions such as rhinitis, pneumonitis, sarcoidosis, asthma exacerbations, COPD exacerbations, anaphylaxis, urticaria, and angioedema. Many respiratory ailments, including asthma and COPD exacerbations, anaphylaxis, urticaria and angioedema, rhinitis, pneumonitis, sarcoidosis, and interstitial lung disease, are treated with corticosteroids. For example, in May 2024, Asthma Australia, a national not-for-profit organization, reported that asthma mortality rates in Australia rose from 349 deaths in 2021 to 455 deaths in 2022, highlighting a concerning trend regarding this chronic respiratory condition. As a result, the increasing incidence of respiratory diseases is propelling the corticosteroids market forward.

An emerging trend in the corticosteroid therapy market is the development of silicones for topical and transdermal drug delivery. Silicone gel sheets and implants are being used to deliver drugs effectively, and silicone-based pressure-sensitive adhesives for transdermal drug delivery show promising results. Silicones offer advantages such as improved drug permeability and high diffusivity, making them efficient for modern drug products.

Major companies in the corticosteroid market are focusing on innovation to expand their customer bases and increase revenue. The development of rescue medications, such as AstraZeneca's Airsupra, indicates a commitment to meeting immediate relief needs for acute symptoms. AstraZeneca's product, a fixed-dose combination rescue medication, received FDA approval in January 2023, containing albuterol and budesonide for bronchoconstriction treatment and asthma exacerbation prevention.

In June 2024, Sun Pharmaceutical Industries Ltd., a specialty generic pharmaceutical company based in India, acquired Taro Pharmaceutical Industries Ltd. for an undisclosed amount. This acquisition aims to enhance Sun Pharma's position in the pharmaceutical market, particularly in the sectors of off-patent pharmaceuticals, prescription medications, and over-the-counter products. Taro Pharmaceutical Industries Ltd., located in Israel, is a research-focused pharmaceutical manufacturer that produces a range of products, including corticosteroids.

Major companies operating in the corticosteroids market include McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Sumitomo Corporation, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Indivior plc, Zizhu Pharmaceutical Co. Ltd., Allergan plc, Hikma Pharmaceuticals plc

North America was the largest region in the corticosteroids therapy market share in 2024. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the corticosteroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The corticosteroids therapy market consists of sales of glucocorticoids, mineralocorticoids, cortisone, hydrocortisone, and prednisone. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Corticosteroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on corticosteroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for corticosteroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The corticosteroids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Glucocorticoids; Mineralocorticoids
• 2) By Application: Skin Allergies; Rheumatology Indications; Endocrinology; Acute Respiratory Diseases; Other Applications
• 3) By End User: Hospitals; Clinics; Research Institutes; Other End Users
• Subsegments:
• 1) By Glucocorticoids: Hydrocortisone; Prednisone; Dexamethasone; Methylprednisolone; Triamcinolone; Betamethasone; Other Glucocorticoids
• 2) By Mineralocorticoids: Fludrocortisone; Aldosterone; Other Mineralocorticoids
• Companies Mentioned: McKesson Corporation; Pfizer Inc.; Johnson and Johnson Services Inc.; Merck & Co.Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Corticosteroids Market Characteristics

3. Corticosteroids Market Trends And Strategies

4. Corticosteroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Corticosteroids Growth Analysis And Strategic Analysis Framework

• 5.1. Global Corticosteroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Corticosteroids Market Growth Rate Analysis
• 5.4. Global Corticosteroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Corticosteroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Corticosteroids Total Addressable Market (TAM)

6. Corticosteroids Market Segmentation

• 6.1. Global Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucocorticoids
• Mineralocorticoids
• 6.2. Global Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Allergies
• Rheumatology Indications
• Endocrinology
• Acute Respiratory Diseases
• Other Applications
• 6.3. Global Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutes
• Other End Users
• 6.4. Global Corticosteroids Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrocortisone
• Prednisone
• Dexamethasone
• Methylprednisolone
• Triamcinolone
• Betamethasone
• Other Glucocorticoids
• 6.5. Global Corticosteroids Market, Sub-Segmentation Of Mineralocorticoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fludrocortisone
• Aldosterone
• Other Mineralocorticoids

7. Corticosteroids Market Regional And Country Analysis

• 7.1. Global Corticosteroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Corticosteroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Corticosteroids Market

• 8.1. Asia-Pacific Corticosteroids Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Corticosteroids Market

• 9.1. China Corticosteroids Market Overview
• 9.2. China Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Corticosteroids Market

• 10.1. India Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Corticosteroids Market

• 11.1. Japan Corticosteroids Market Overview
• 11.2. Japan Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Corticosteroids Market

• 12.1. Australia Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Corticosteroids Market

• 13.1. Indonesia Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Corticosteroids Market

• 14.1. South Korea Corticosteroids Market Overview
• 14.2. South Korea Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Corticosteroids Market

• 15.1. Western Europe Corticosteroids Market Overview
• 15.2. Western Europe Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Corticosteroids Market

• 16.1. UK Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Corticosteroids Market

• 17.1. Germany Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Corticosteroids Market

• 18.1. France Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Corticosteroids Market

• 19.1. Italy Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Corticosteroids Market

• 20.1. Spain Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Corticosteroids Market

• 21.1. Eastern Europe Corticosteroids Market Overview
• 21.2. Eastern Europe Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Corticosteroids Market

• 22.1. Russia Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Corticosteroids Market

• 23.1. North America Corticosteroids Market Overview
• 23.2. North America Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Corticosteroids Market

• 24.1. USA Corticosteroids Market Overview
• 24.2. USA Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Corticosteroids Market

• 25.1. Canada Corticosteroids Market Overview
• 25.2. Canada Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Corticosteroids Market

• 26.1. South America Corticosteroids Market Overview
• 26.2. South America Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Corticosteroids Market

• 27.1. Brazil Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Corticosteroids Market

• 28.1. Middle East Corticosteroids Market Overview
• 28.2. Middle East Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Corticosteroids Market

• 29.1. Africa Corticosteroids Market Overview
• 29.2. Africa Corticosteroids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Corticosteroids Market Competitive Landscape And Company Profiles

• 30.1. Corticosteroids Market Competitive Landscape
• 30.2. Corticosteroids Market Company Profiles
  • 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Corticosteroids Market Other Major And Innovative Companies

• 31.1. Sumitomo Corporation
• 31.2. Novartis International AG
• 31.3. Sanofi SA
• 31.4. Bristol Myers Squibb Company
• 31.5. AstraZeneca plc
• 31.6. Abbott Laboratories
• 31.7. GlaxoSmithKline plc
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lilly and Company
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Novo Nordisk A/S
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Regeneron Pharmaceuticals Inc.
• 31.14. Sun Pharmaceutical Industries Ltd.
• 31.15. Cipla Limited

32. Global Corticosteroids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Corticosteroids Market

34. Recent Developments In The Corticosteroids Market

35. Corticosteroids Market High Potential Countries, Segments and Strategies

• 35.1 Corticosteroids Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Corticosteroids Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Corticosteroids Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer